Lucioni Marco, Morello Gaia, Cristinelli Caterina, Fraticelli Sara, Neri Giuseppe, Travaglino Erica, Minetto Marco, Antoci Francesca, Libretti Paolo, Gambacorta Marcello, Arcaini Luca, Tripodo Claudio, Paulli Marco
Department of Molecular Medicine University of Pavia Pavia Italy.
Pathology Unit, Fondazione IRCCS Policlinico "San Matteo" Pavia Italy.
EJHaem. 2024 Oct 23;5(6):1182-1189. doi: 10.1002/jha2.1034. eCollection 2024 Dec.
Castleman disease (CD) represents a spectrum of heterogeneous lymphoproliferative disorders sharing peculiar histopathological features, clinically subdivided into unicentric CD (UCD) and multicentric CD (MCD) and presenting with variable inflammatory symptoms. Interleukin (IL)-6 and other cytokines play a major role in mediating CD inflammatory manifestations. Although the local microenvironment seems to be among the major sources of hypercytokinemia, the precise cellular origin of IL-6 production in CD is still debated.
A series of five nodal CD of different subtypes (one UCD, two idiopathic MCDs [iMCDs], one HIV-negative human herpesvirus 8 (HHV8)-associated MCD, and one HIV-positive HHV8-associated MCD) and a non-CD reactive control were tested using RNAscope analysis and a dual in situ hybridization (ISH)/immunohistochemistry technique, in order to quantify IL-6 expression and its spatial distribution. Quantitative analyses of in situ mRNA were performed on digitalized slides using the HISTOQUANT software (3DHISTECH) and differences between cases were evaluated by the Kruskal-Wallis test.
RNA-ISH documented increased expression in all CD lymph nodes, independently from clinical and pathological subtypes, however, the highest levels were found in HHV8+ cases and statistically significant differences in IL-6 expression were found only between HHV8+ MCD and control case. Dual RNA-ISH for coupled with immunohistochemistry analysis showed that IL-6 was overexpressed in CD31-positive endothelial cells in 5/5 CD tested cases but not in the control case.
Our findings suggest that nodal IL-6 expression seems to be significantly upregulated in HHV8+ MCD, but a trend toward increased nodal IL-6 expression was noticed also in UCD and iMCD-not otherwise specified. CD31+ endothelial cells probably represent one of the major sources of IL-6 production in the nodal microenvironment.
卡斯特曼病(CD)是一系列具有独特组织病理学特征的异质性淋巴增殖性疾病,临床上分为单中心型CD(UCD)和多中心型CD(MCD),并伴有多种炎症症状。白细胞介素(IL)-6和其他细胞因子在介导CD的炎症表现中起主要作用。尽管局部微环境似乎是高细胞因子血症的主要来源之一,但CD中IL-6产生的确切细胞来源仍存在争议。
使用RNAscope分析和双重原位杂交(ISH)/免疫组织化学技术对一系列五个不同亚型的淋巴结CD(一个UCD、两个特发性MCD [iMCD]、一个HIV阴性人疱疹病毒8(HHV8)相关MCD和一个HIV阳性HHV8相关MCD)以及一个非CD反应性对照进行检测,以量化IL-6的表达及其空间分布。使用HISTOQUANT软件(3DHISTECH)对数字化玻片上的原位mRNA进行定量分析,并通过Kruskal-Wallis检验评估病例之间的差异。
RNA-ISH记录了所有CD淋巴结中的表达增加,与临床和病理亚型无关,然而,在HHV8阳性病例中发现了最高水平,并且仅在HHV8阳性MCD和对照病例之间发现了IL-6表达的统计学显著差异。双重RNA-ISH与免疫组织化学分析显示,在5/5个测试的CD病例中,IL-6在CD31阳性内皮细胞中过表达,但在对照病例中未过表达。
我们的研究结果表明,HHV8阳性MCD中淋巴结IL-6表达似乎显著上调,但在UCD和未另作说明的iMCD中也注意到淋巴结IL-6表达增加的趋势。CD31 +内皮细胞可能是淋巴结微环境中IL-6产生的主要来源之一。